These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 20170

  • 1. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
    Delitala G, Masala A.
    Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170
    [Abstract] [Full Text] [Related]

  • 2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB, Scott CL, Modebe O, Bethune JE.
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [Abstract] [Full Text] [Related]

  • 4. Action of somatostatin, levodopa and pyridoxine on growth hormone (GH) secretion in newborn infants.
    Delitala G, Meloni T, Masala A, Alagna S, Devilla L, Costa R.
    Biomedicine; 1978 Feb; 29(1):13-5. PubMed ID: 667280
    [Abstract] [Full Text] [Related]

  • 5. Suppression of pimozide-induced prolactin secretion by piridoxine (vitamin B6).
    Delitala G, Masala A, Alagna S.
    Biomedicine; 1977 Jul; 27(5):191-2. PubMed ID: 562688
    [Abstract] [Full Text] [Related]

  • 6. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA, Frohman LA.
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [Abstract] [Full Text] [Related]

  • 7. Pyridoxine and depression: neuroendocrine aspects.
    Casacchia M, Boni B, Meco G.
    Acta Vitaminol Enzymol; 1982 Apr; 4(1-2):55-8. PubMed ID: 6812398
    [Abstract] [Full Text] [Related]

  • 8. Effect of pyridoxine on pituitary release of growth hormone and prolactin in childhood and adolescence.
    Reiter EO, Root AW.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):689-90. PubMed ID: 263321
    [Abstract] [Full Text] [Related]

  • 9. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
    Esquifino AI, Fernández-Ruiz JJ, Cebeira M, Agrasal C, Tresguerres JA, Ramos JA.
    Rev Esp Fisiol; 1987 Dec; 43(4):463-8. PubMed ID: 3448711
    [Abstract] [Full Text] [Related]

  • 10. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
    Giusti M, Giovale M, Sessarego P, Carraro A, Pompei A, Giordano G.
    Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
    [Abstract] [Full Text] [Related]

  • 11. The effect of acetylsalicylic acid and diclofenac on stimulated growth hormone and prolactin secretion in humans.
    Caviezel F, Cattaneo AG, Tell A, Corino T, Mascherpa M.
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):502-4. PubMed ID: 6642786
    [Abstract] [Full Text] [Related]

  • 12. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
    Lancranjan I, Wirz-Justice A, Pühringer W, Del Pozo E.
    J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
    [Abstract] [Full Text] [Related]

  • 13. Dynamic evaluation of prolactin secretion during the early hours of life in human newborns.
    Delitala G, Meloni T, Masala A, Alagna S, Devilla L, Corti R.
    J Clin Endocrinol Metab; 1978 Jun; 46(6):880-2. PubMed ID: 122439
    [Abstract] [Full Text] [Related]

  • 14. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS, Jacobs LS.
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [Abstract] [Full Text] [Related]

  • 15. The effects of l-DOPA and sulpiride on growth hormone secretion at different injection times in Holstein steers.
    Kasuya E, Sutoh M, Yayou KI.
    Anim Sci J; 2017 Nov; 88(11):1842-1848. PubMed ID: 28585780
    [Abstract] [Full Text] [Related]

  • 16. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD, Lantigua R, Lee LA.
    J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
    [No Abstract] [Full Text] [Related]

  • 17. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
    Bansal S, Lee LA, Woolf PD.
    J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
    [No Abstract] [Full Text] [Related]

  • 18. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G, Maioli M, Pacifico A, Brianda S, Palermo M, Mannelli M.
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
    [Abstract] [Full Text] [Related]

  • 19. Pyridoxine (B6) suppresses the rise in prolactin and increases the rise in growth hormone induced by exercise.
    Moretti C, Fabbri A, Gnessi L, Bonifacio V, Fraioli F, Isidori A.
    N Engl J Med; 1982 Aug 12; 307(7):444-5. PubMed ID: 7088124
    [No Abstract] [Full Text] [Related]

  • 20. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H, Yen SS.
    Am J Obstet Gynecol; 1976 Sep 15; 126(2):162-4. PubMed ID: 961756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.